| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | HCN4 HCN1 SLC6A15 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 | 4.44e-07 | 171 | 110 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | HCN4 TRPM7 HCN1 PKD1L1 SLC6A15 PKD1L3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 1.71e-06 | 465 | 110 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.96e-06 | 17 | 110 | 4 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 3.17e-06 | 19 | 110 | 4 | GO:0015373 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 4.58e-06 | 431 | 110 | 12 | GO:0004984 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.65e-06 | 81 | 110 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 7.12e-06 | 23 | 110 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.19e-05 | 26 | 110 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.33e-05 | 9 | 110 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 ABCC4 HCN4 TRPM7 HCN1 PKD1L1 SLC6A15 PKD1L3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 1.75e-05 | 758 | 110 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | symporter activity | 1.96e-05 | 150 | 110 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 2.68e-05 | 884 | 110 | 16 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 HCN4 TRPM7 HCN1 PKD1L1 SLC6A15 PKD1L3 TMC3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 2.96e-05 | 793 | 110 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | HCN4 TRPM7 HCN1 PKD1L1 SLC6A15 PKD1L3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 4.14e-05 | 627 | 110 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.10e-05 | 119 | 110 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | HCN4 TRPM7 HCN1 PKD1L1 SLC6A15 PKD1L3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 7.42e-05 | 664 | 110 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | ANO4 ABCC4 HCN4 TRPM7 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 TMC3 GJD4 CLPTM1L SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 7.42e-05 | 1289 | 110 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 ABCC4 HCN4 TRPM7 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 TMC3 GJD4 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SCN10A SLC28A1 TRPV3 | 7.62e-05 | 1180 | 110 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 8.99e-05 | 3 | 110 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 8.99e-05 | 3 | 110 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.05e-04 | 17 | 110 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PKD1L3 PTGER3 OR4P4 OR10AG1 PTPRK OR1K1 FGFR2 OR4D5 OR4C5 | 1.40e-04 | 1353 | 110 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.71e-04 | 171 | 110 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.86e-04 | 26 | 110 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 5.34e-04 | 120 | 110 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.43e-04 | 125 | 110 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | channel activity | 6.48e-04 | 525 | 110 | 10 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.57e-04 | 526 | 110 | 10 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.91e-04 | 459 | 110 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.06e-03 | 9 | 110 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.27e-03 | 296 | 110 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.31e-03 | 10 | 110 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.50e-03 | 151 | 110 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 1.83e-03 | 44 | 110 | 3 | GO:0004520 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 1.91e-03 | 12 | 110 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | N-acetyl-beta-D-glucosaminide beta-(1,3)-galactosyltransferase activity | 1.91e-03 | 12 | 110 | 2 | GO:0008499 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.91e-03 | 12 | 110 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 2.25e-03 | 13 | 110 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 2.25e-03 | 13 | 110 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 2.62e-03 | 14 | 110 | 2 | GO:0016888 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.92e-03 | 343 | 110 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.95e-03 | 52 | 110 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | beta-1,3-galactosyltransferase activity | 3.01e-03 | 15 | 110 | 2 | GO:0048531 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 3.43e-03 | 16 | 110 | 2 | GO:0004707 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 3.87e-03 | 17 | 110 | 2 | GO:0005545 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC4 SLC6A17 SLC6A15 SLC12A1 SLC12A3 SLC18A1 SLC22A3 SLC28A1 | 4.90e-03 | 477 | 110 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 5.36e-03 | 20 | 110 | 2 | GO:0035259 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 OR13F1 PKD1L1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 SCN10A REG3A OR1K1 OR4D5 OR4C5 | 3.11e-07 | 722 | 111 | 17 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO4 ABCC4 MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 TMC3 SLC12A1 SLC12A3 SLC18A1 GNB5 SCN10A TRPV3 OGA | 4.50e-07 | 1115 | 111 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 SCN10A OR1K1 OR4D5 OR4C5 | 5.35e-07 | 582 | 111 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 REG3A OR1K1 OR4D5 OR4C5 | 8.64e-07 | 524 | 111 | 14 | GO:0009593 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO4 ABCC4 HTR7 MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 TMC3 SLC12A1 SLC12A3 SLC18A1 SLC22A3 GNB5 SCN10A TRPV3 OGA | 9.17e-07 | 1374 | 111 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO4 MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 SLC12A1 SLC12A3 SLC18A1 GNB5 SCN10A TRPV3 OGA | 1.94e-06 | 1017 | 111 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 SLC12A1 SLC12A3 SLC18A1 GNB5 SCN10A TRPV3 OGA | 2.02e-06 | 922 | 111 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 2.11e-06 | 485 | 111 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 SLC12A1 SLC12A3 SLC18A1 GNB5 SCN10A TRPV3 OGA | 2.74e-06 | 942 | 111 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 3.72e-06 | 432 | 111 | 12 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 7.79e-06 | 547 | 111 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 7.84e-06 | 465 | 111 | 12 | GO:0007608 |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 1.93e-05 | 61 | 111 | 5 | GO:0003254 | |
| GeneOntologyBiologicalProcess | metal ion transport | MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 SLC12A1 SLC12A3 GNB5 SCN10A TRPV3 OGA | 2.44e-05 | 1000 | 111 | 17 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | MYO5A HCN4 TRPM7 PMPCB GPR39 HCN1 SLC6A17 PKD1L1 SLC6A15 PKD1L3 PTGER3 SLC12A1 SLC12A3 SLC18A1 GNB5 SCN10A TRPV3 OGA | 4.41e-05 | 1157 | 111 | 18 | GO:0006812 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | ADCY10 OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 GPR180 OR4P4 OR10AG1 GNB5 OR1K1 OR4D5 PSAPL1 OR4C5 | 5.00e-05 | 1395 | 111 | 20 | GO:0007186 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 5.14e-05 | 392 | 111 | 10 | GO:0070588 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 6.25e-05 | 40 | 111 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.34e-04 | 208 | 111 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 1.76e-04 | 52 | 111 | 4 | GO:0048701 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.80e-04 | 153 | 111 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | sensory perception | OR4K2 OR2L3 HTR7 MYO5A OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 PKD1L3 OR4P4 OR10AG1 SCN10A OR1K1 OR4D5 OR4C5 | 1.97e-04 | 1072 | 111 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 2.35e-04 | 56 | 111 | 4 | GO:0010837 | |
| GeneOntologyBiologicalProcess | negative regulation of gastric acid secretion | 2.84e-04 | 5 | 111 | 2 | GO:0060455 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 3.60e-04 | 26 | 111 | 3 | GO:0017121 | |
| GeneOntologyBiologicalProcess | monoamine transport | 4.11e-04 | 116 | 111 | 5 | GO:0015844 | |
| GeneOntologyBiologicalProcess | galactosylceramide biosynthetic process | 4.24e-04 | 6 | 111 | 2 | GO:0006682 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 4.24e-04 | 6 | 111 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | galactolipid biosynthetic process | 4.24e-04 | 6 | 111 | 2 | GO:0019375 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 4.26e-04 | 509 | 111 | 10 | GO:0006816 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.99e-04 | 121 | 111 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | negative regulation of keratinocyte proliferation | 5.01e-04 | 29 | 111 | 3 | GO:0010839 | |
| GeneOntologyBiologicalProcess | keratinocyte proliferation | 5.54e-04 | 70 | 111 | 4 | GO:0043616 | |
| GeneOntologyBiologicalProcess | protein processing involved in protein targeting to mitochondrion | 5.92e-04 | 7 | 111 | 2 | GO:0006627 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 7.79e-06 | 8 | 110 | 3 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 1.66e-05 | 10 | 110 | 3 | GO:0071141 | |
| GeneOntologyCellularComponent | HCN channel complex | 1.64e-04 | 4 | 110 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | presynaptic endosome | 5.66e-04 | 7 | 110 | 2 | GO:0098830 | |
| Domain | 7tm_1 | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 1.93e-06 | 677 | 109 | 16 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 2.24e-06 | 685 | 109 | 16 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 2.51e-06 | 691 | 109 | 16 | PS50262 |
| Domain | GPCR_Rhodpsn | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 2.56e-06 | 692 | 109 | 16 | IPR000276 |
| Domain | Olfact_rcpt | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 3.18e-06 | 393 | 109 | 12 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR4K2 OR2L3 HTR7 OR4C16 OR2T35 GPR39 OR13F1 GPR173 OR2W1 OR2T2 PTGER3 OR4P4 OR10AG1 OR1K1 OR4D5 | 7.99e-06 | 670 | 109 | 15 | IPR017452 |
| Domain | Dwarfin | 1.06e-05 | 8 | 109 | 3 | IPR013790 | |
| Domain | DWB | 1.06e-05 | 8 | 109 | 3 | SM00524 | |
| Domain | MH2 | 1.06e-05 | 8 | 109 | 3 | PS51076 | |
| Domain | MH1 | 1.06e-05 | 8 | 109 | 3 | PS51075 | |
| Domain | - | 1.06e-05 | 8 | 109 | 3 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.06e-05 | 8 | 109 | 3 | IPR013019 | |
| Domain | MH2 | 1.06e-05 | 8 | 109 | 3 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.06e-05 | 8 | 109 | 3 | IPR001132 | |
| Domain | Mediator_Med12 | 3.37e-05 | 2 | 109 | 2 | IPR019035 | |
| Domain | Med12 | 3.37e-05 | 2 | 109 | 2 | PF09497 | |
| Domain | Mediator_Med12_LCEWAV | 3.37e-05 | 2 | 109 | 2 | IPR021990 | |
| Domain | Mediator_Med12_catenin-bd | 3.37e-05 | 2 | 109 | 2 | IPR021989 | |
| Domain | Med12-PQL | 3.37e-05 | 2 | 109 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 3.37e-05 | 2 | 109 | 2 | PF12145 | |
| Domain | Med12 | 3.37e-05 | 2 | 109 | 2 | SM01281 | |
| Domain | MAD_homology1_Dwarfin-type | 4.09e-05 | 12 | 109 | 3 | IPR003619 | |
| Domain | DWA | 4.09e-05 | 12 | 109 | 3 | SM00523 | |
| Domain | MH1 | 4.09e-05 | 12 | 109 | 3 | PF03165 | |
| Domain | AA_permease_N | 1.01e-04 | 3 | 109 | 2 | IPR013612 | |
| Domain | AA_permease_N | 1.01e-04 | 3 | 109 | 2 | PF08403 | |
| Domain | SMAD_dom-like | 1.02e-04 | 16 | 109 | 3 | IPR017855 | |
| Domain | - | 1.02e-04 | 16 | 109 | 3 | 2.60.200.10 | |
| Domain | Ion_trans_N | 2.01e-04 | 4 | 109 | 2 | PF08412 | |
| Domain | Ion_trans_N | 2.01e-04 | 4 | 109 | 2 | IPR013621 | |
| Domain | Na/ntran_symport_orphan | 3.34e-04 | 5 | 109 | 2 | IPR002438 | |
| Domain | MAPK_JNK | 3.34e-04 | 5 | 109 | 2 | IPR008351 | |
| Domain | Myosin_S1_N | 3.34e-04 | 5 | 109 | 2 | IPR008989 | |
| Domain | WD40_repeat_CS | 4.02e-04 | 164 | 109 | 6 | IPR019775 | |
| Domain | DIL | 4.99e-04 | 6 | 109 | 2 | PF01843 | |
| Domain | Dilute_dom | 4.99e-04 | 6 | 109 | 2 | IPR002710 | |
| Domain | DILUTE | 4.99e-04 | 6 | 109 | 2 | PS51126 | |
| Domain | DIL | 4.99e-04 | 6 | 109 | 2 | SM01132 | |
| Domain | Ion_trans_dom | 5.47e-04 | 114 | 109 | 5 | IPR005821 | |
| Domain | Ion_trans | 5.47e-04 | 114 | 109 | 5 | PF00520 | |
| Domain | SLC12A_fam | 6.95e-04 | 7 | 109 | 2 | IPR004842 | |
| Domain | WD40 | 8.15e-04 | 259 | 109 | 7 | PF00400 | |
| Domain | SLC12_C | 9.24e-04 | 8 | 109 | 2 | IPR018491 | |
| Domain | SLC12 | 9.24e-04 | 8 | 109 | 2 | PF03522 | |
| Domain | WD40 | 9.94e-04 | 268 | 109 | 7 | SM00320 | |
| Domain | WD40_repeat | 1.08e-03 | 272 | 109 | 7 | IPR001680 | |
| Domain | PAZ | 1.18e-03 | 9 | 109 | 2 | PS50821 | |
| Domain | PAZ | 1.18e-03 | 9 | 109 | 2 | SM00949 | |
| Domain | PAZ_dom | 1.18e-03 | 9 | 109 | 2 | IPR003100 | |
| Domain | PAZ | 1.18e-03 | 9 | 109 | 2 | PF02170 | |
| Domain | WD_REPEATS_1 | 1.23e-03 | 278 | 109 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.25e-03 | 279 | 109 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.25e-03 | 279 | 109 | 7 | PS50294 | |
| Domain | G-protein_beta_WD-40_rep | 1.55e-03 | 85 | 109 | 4 | IPR020472 | |
| Domain | WD40_repeat_dom | 1.79e-03 | 297 | 109 | 7 | IPR017986 | |
| Domain | PKD_channel | 1.79e-03 | 11 | 109 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 1.79e-03 | 11 | 109 | 2 | IPR013122 | |
| Domain | MAP_kinase_CS | 2.14e-03 | 12 | 109 | 2 | IPR003527 | |
| Domain | MAPK | 2.14e-03 | 12 | 109 | 2 | PS01351 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 2.93e-03 | 14 | 109 | 2 | IPR003938 | |
| Domain | - | 3.39e-03 | 333 | 109 | 7 | 2.130.10.10 | |
| Domain | SMAD_FHA_domain | 3.47e-03 | 52 | 109 | 3 | IPR008984 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.51e-03 | 335 | 109 | 7 | IPR015943 | |
| Domain | ARM-type_fold | 3.74e-03 | 339 | 109 | 7 | IPR016024 | |
| Domain | Glyco_trans_31 | 3.84e-03 | 16 | 109 | 2 | IPR002659 | |
| Domain | cNMP-bd_CS | 3.84e-03 | 16 | 109 | 2 | IPR018488 | |
| Domain | Galactosyl_T | 3.84e-03 | 16 | 109 | 2 | PF01762 | |
| Domain | - | 3.84e-03 | 16 | 109 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.84e-03 | 16 | 109 | 2 | SM00146 | |
| Domain | LH2 | 4.86e-03 | 18 | 109 | 2 | SM00308 | |
| Domain | PI3/4_kinase_cat_dom | 4.86e-03 | 18 | 109 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.86e-03 | 18 | 109 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.86e-03 | 18 | 109 | 2 | PS50290 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.86e-03 | 18 | 109 | 2 | PS00754 | |
| Domain | PI3_4_KINASE_1 | 4.86e-03 | 18 | 109 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.86e-03 | 18 | 109 | 2 | PS00916 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.41e-03 | 19 | 109 | 2 | PS00452 | |
| Domain | SNF | 5.41e-03 | 19 | 109 | 2 | PF00209 | |
| Domain | Guanylate_cyc | 5.41e-03 | 19 | 109 | 2 | PF00211 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.41e-03 | 19 | 109 | 2 | PS00610 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.41e-03 | 19 | 109 | 2 | PS50125 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.41e-03 | 19 | 109 | 2 | PS50267 | |
| Domain | A/G_cyclase | 5.41e-03 | 19 | 109 | 2 | IPR001054 | |
| Domain | CYCc | 5.41e-03 | 19 | 109 | 2 | SM00044 | |
| Domain | Na/ntran_symport | 5.41e-03 | 19 | 109 | 2 | IPR000175 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR2T2 OR4P4 OR10AG1 OR1K1 OR4D5 OR4C5 | 1.30e-05 | 417 | 90 | 12 | M4072 |
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 3.43e-08 | 3 | 114 | 3 | 28131828 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 23584254 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 19247629 | ||
| Pubmed | Bmp7 drives proximal tubule expansion and determines nephron number in the developing kidney. | 1.93e-07 | 16 | 114 | 4 | 35877077 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR4P4 OR10AG1 OR4D5 OR4C5 | 1.93e-07 | 340 | 114 | 10 | 11875048 |
| Pubmed | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR4P4 OR10AG1 OR4D5 OR4C5 | 1.93e-07 | 340 | 114 | 10 | 11802173 | |
| Pubmed | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR4P4 OR10AG1 OR4D5 OR4C5 | 2.10e-07 | 343 | 114 | 10 | 32295537 | |
| Pubmed | OR4K2 OR2L3 OR4C16 OR2T35 OR13F1 OR2W1 OR4P4 OR10AG1 OR4D5 OR4C5 | 2.27e-07 | 346 | 114 | 10 | 14611657 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 15647271 | ||
| Pubmed | The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. | 3.41e-07 | 5 | 114 | 3 | 17251190 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 19819941 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 25141865 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 8673135 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 5.09e-07 | 20 | 114 | 4 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 5.09e-07 | 20 | 114 | 4 | 32662771 | |
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 6.81e-07 | 6 | 114 | 3 | 18393632 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 10400677 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 6.81e-07 | 6 | 114 | 3 | 18952608 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 11169847 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 11850197 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 15009097 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 1.19e-06 | 7 | 114 | 3 | 14699069 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 10376010 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 1.19e-06 | 7 | 114 | 3 | 11163184 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 15150273 | ||
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 12370310 | ||
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 1.19e-06 | 7 | 114 | 3 | 14580334 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 23933588 | ||
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 1.90e-06 | 8 | 114 | 3 | 19211612 | |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 10647776 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 12714599 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 10531362 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 23804438 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 11278251 | ||
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 10708949 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 2.84e-06 | 9 | 114 | 3 | 24932701 | |
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 19018011 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 9759503 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 30134160 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 24816837 | ||
| Pubmed | Persistent Noggin arrests cardiomyocyte morphogenesis and results in early in utero lethality. | 2.84e-06 | 9 | 114 | 3 | 25428115 | |
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 2.84e-06 | 9 | 114 | 3 | 25155999 | |
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 10708948 | ||
| Pubmed | The non-canonical BMP and Wnt/β-catenin signaling pathways orchestrate early tooth development. | 3.67e-06 | 32 | 114 | 4 | 25428587 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 9076683 | ||
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 4.05e-06 | 10 | 114 | 3 | 29247325 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 23620745 | ||
| Pubmed | The crucial role of the TRPM7 kinase domain in the early stage of amelogenesis. | 4.05e-06 | 10 | 114 | 3 | 29273814 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 15221015 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 4.05e-06 | 10 | 114 | 3 | 29986157 | |
| Pubmed | 4.05e-06 | 10 | 114 | 3 | 22300732 | ||
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 4.05e-06 | 10 | 114 | 3 | 12543979 | |
| Pubmed | 4.16e-06 | 33 | 114 | 4 | 19834762 | ||
| Pubmed | 5.30e-06 | 35 | 114 | 4 | 18676816 | ||
| Pubmed | Mechanical feedback defines organizing centers to drive digit emergence. | 5.55e-06 | 11 | 114 | 3 | 35413235 | |
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 5.55e-06 | 11 | 114 | 3 | 27741240 | |
| Pubmed | 5.55e-06 | 11 | 114 | 3 | 24008158 | ||
| Pubmed | Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development. | 5.95e-06 | 36 | 114 | 4 | 29891551 | |
| Pubmed | EED MYO5A ACADVL TRPM7 PMPCB NOC2L TMEM126B SLC6A15 DICER1 TBL3 MPRIP CLPTM1L THADA PI4KA RAB3GAP2 IFT80 OGA | 7.13e-06 | 1487 | 114 | 17 | 33957083 | |
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 21538804 | ||
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 14656760 | ||
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 17460146 | ||
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 9.58e-06 | 13 | 114 | 3 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 9.58e-06 | 13 | 114 | 3 | 18329379 | |
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 9.58e-06 | 13 | 114 | 3 | 19914168 | |
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 9.58e-06 | 13 | 114 | 3 | 17628518 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 17670747 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 26711875 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 1.07e-05 | 2 | 114 | 2 | 17548059 | |
| Pubmed | The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. | 1.07e-05 | 2 | 114 | 2 | 11451566 | |
| Pubmed | Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. | 1.07e-05 | 2 | 114 | 2 | 19147495 | |
| Pubmed | Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes. | 1.07e-05 | 2 | 114 | 2 | 25422309 | |
| Pubmed | BMP-SMAD1/5 Signaling Regulates Retinal Vascular Development. | 1.07e-05 | 2 | 114 | 2 | 32210087 | |
| Pubmed | Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity. | 1.07e-05 | 2 | 114 | 2 | 23878236 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 35403677 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23387849 | ||
| Pubmed | Human myosin-Vc is a novel class V myosin expressed in epithelial cells. | 1.07e-05 | 2 | 114 | 2 | 11870218 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8799132 | ||
| Pubmed | Structure of Smad1 MH1/DNA complex reveals distinctive rearrangements of BMP and TGF-beta effectors. | 1.07e-05 | 2 | 114 | 2 | 20147459 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 37957716 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 18446813 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23658184 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 21723296 | ||
| Pubmed | Regulation of the levels of Smad1 and Smad5 in MC3T3-E1 cells by Icariine in vitro. | 1.07e-05 | 2 | 114 | 2 | 24297369 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 1.07e-05 | 2 | 114 | 2 | 11675786 | |
| Pubmed | Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. | 1.07e-05 | 2 | 114 | 2 | 20702715 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9417100 | ||
| Pubmed | Myosin Va Brain-Specific Mutation Alters Mouse Behavior and Disrupts Hippocampal Synapses. | 1.07e-05 | 2 | 114 | 2 | 33229412 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 30338939 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 19135060 | ||
| Pubmed | Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin. | 1.07e-05 | 2 | 114 | 2 | 26912658 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 37968800 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 8021284 | ||
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 1.22e-05 | 14 | 114 | 3 | 17670744 | |
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 38951500 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 17693062 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 1.22e-05 | 14 | 114 | 3 | 33248111 | |
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 16790475 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 25488669 | ||
| Cytoband | 15q21 | 2.43e-06 | 11 | 114 | 3 | 15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 8.41e-05 | 177 | 114 | 5 | chr15q21 | |
| Cytoband | 17p13.1 | 2.23e-04 | 118 | 114 | 4 | 17p13.1 | |
| Cytoband | 10q26 | 1.49e-03 | 23 | 114 | 2 | 10q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.77e-03 | 346 | 114 | 5 | chr17p13 | |
| Cytoband | 1q44 | 2.65e-03 | 110 | 114 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 4.06e-03 | 128 | 114 | 3 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q11 | 4.48e-03 | 40 | 114 | 2 | chr11q11 | |
| GeneFamily | SMAD family | 5.33e-06 | 8 | 84 | 3 | 750 | |
| GeneFamily | Myosins, class V | 6.38e-05 | 3 | 84 | 2 | 1100 | |
| GeneFamily | WD repeat domain containing | 2.17e-04 | 262 | 84 | 7 | 362 | |
| GeneFamily | Olfactory receptors, family 4 | 3.36e-04 | 129 | 84 | 5 | 151 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.08e-04 | 41 | 84 | 3 | 1298 | |
| GeneFamily | Cyclic nucleotide gated channels | 9.37e-04 | 10 | 84 | 2 | 250 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.37e-03 | 12 | 84 | 2 | 1290 | |
| GeneFamily | Mitogen-activated protein kinases | 1.61e-03 | 13 | 84 | 2 | 651 | |
| GeneFamily | Olfactory receptors, family 2 | 1.90e-03 | 113 | 84 | 4 | 149 | |
| GeneFamily | Solute carriers | 2.41e-03 | 395 | 84 | 7 | 752 | |
| GeneFamily | Beta 3-glycosyltransferases | 5.51e-03 | 24 | 84 | 2 | 426 | |
| GeneFamily | Transient receptor potential cation channels | 7.45e-03 | 28 | 84 | 2 | 249 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 7.98e-03 | 29 | 84 | 2 | 754 | |
| GeneFamily | Cyclins|Mediator complex | 1.03e-02 | 33 | 84 | 2 | 1061 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.86e-07 | 184 | 114 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.04e-07 | 185 | 114 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 5.04e-07 | 185 | 114 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 5.41e-07 | 187 | 114 | 7 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.61e-07 | 188 | 114 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.24e-07 | 191 | 114 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 6.46e-07 | 192 | 114 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.46e-07 | 192 | 114 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-07 | 199 | 114 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 130 | 114 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.16e-06 | 93 | 114 | 5 | af489f0dd76c3c1a84d164283149f550a7ece91c | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.16e-06 | 93 | 114 | 5 | c1d0afcfa37c2dcbb12189b4ce56ae7c4bb7ba30 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.16e-06 | 93 | 114 | 5 | 0ea74c2820372d60d3804bf2c8bb0d03733dff98 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.42e-06 | 166 | 114 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.81e-06 | 179 | 114 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-06 | 181 | 114 | 6 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 188 | 114 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 9.01e-06 | 188 | 114 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 9.29e-06 | 189 | 114 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.57e-06 | 190 | 114 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.86e-06 | 191 | 114 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.86e-06 | 191 | 114 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 9.86e-06 | 191 | 114 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.86e-06 | 191 | 114 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 9.86e-06 | 191 | 114 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 193 | 114 | 6 | 3d4411b3c1cb160dec5db29f0c126d8827dfe185 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-05 | 194 | 114 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.11e-05 | 195 | 114 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.14e-05 | 196 | 114 | 6 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 114 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.33e-05 | 71 | 114 | 4 | 2220e1b02baa71961cfc85536bafeb313e588bf3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.33e-05 | 71 | 114 | 4 | cc5de8bbcfefa2bf93cc137c74b49a745d5da229 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-05 | 160 | 114 | 5 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-05 | 160 | 114 | 5 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-05 | 160 | 114 | 5 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 167 | 114 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.64e-05 | 170 | 114 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 8.30e-05 | 173 | 114 | 5 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.30e-05 | 173 | 114 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-05 | 175 | 114 | 5 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.49e-05 | 178 | 114 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.75e-05 | 179 | 114 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.75e-05 | 179 | 114 | 5 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 181 | 114 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.03e-04 | 181 | 114 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-04 | 184 | 114 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 5b0695b1fbc8e4230f8f0669373ea10af82a0130 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 6485d0d34bdab337b747c0ea2d75e8fad8486b4d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 185 | 114 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-04 | 186 | 114 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 187 | 114 | 5 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 188 | 114 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 188 | 114 | 5 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 189 | 114 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 190 | 114 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 190 | 114 | 5 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-04 | 191 | 114 | 5 | 3839bf57419d3ec3d4464277bb33301d2b7d701f | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-04 | 191 | 114 | 5 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.35e-04 | 192 | 114 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-04 | 192 | 114 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-04 | 192 | 114 | 5 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 193 | 114 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.39e-04 | 193 | 114 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 193 | 114 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-04 | 193 | 114 | 5 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 194 | 114 | 5 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 194 | 114 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 194 | 114 | 5 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | HSPCs-Mk_prog.|World / Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | 5049f4f102844d766eca577e809cf21f7908a9d2 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 195 | 114 | 5 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 195 | 114 | 5 | 1e794839a251fbc6e6ce419b4c457ead35a04735 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 195 | 114 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 196 | 114 | 5 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-04 | 196 | 114 | 5 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 197 | 114 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 197 | 114 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-04 | 198 | 114 | 5 | fcf53d6ac2e442400fa0c07c6de72e00a9143ba2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 198 | 114 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.60e-04 | 199 | 114 | 5 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 1.60e-04 | 199 | 114 | 5 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.64e-04 | 200 | 114 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.02e-05 | 53 | 106 | 4 | C4707243 | |
| Disease | Drug habituation | 6.10e-05 | 115 | 106 | 5 | C0013170 | |
| Disease | Drug abuse | 6.10e-05 | 115 | 106 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 6.10e-05 | 115 | 106 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 6.10e-05 | 115 | 106 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 6.10e-05 | 115 | 106 | 5 | C0013222 | |
| Disease | Drug Dependence | 6.10e-05 | 115 | 106 | 5 | C1510472 | |
| Disease | Substance Dependence | 6.10e-05 | 115 | 106 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 6.10e-05 | 115 | 106 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 6.10e-05 | 115 | 106 | 5 | C0029231 | |
| Disease | Substance abuse problem | 6.36e-05 | 116 | 106 | 5 | C0740858 | |
| Disease | Ovarian Serous Adenocarcinoma | 7.57e-05 | 23 | 106 | 3 | C1335177 | |
| Disease | testosterone measurement | B3GALT1 MYO5A ACADVL CYP7A1 DNAH2 CSMD3 GPR180 PNMA6F THADA SLC22A3 SLC28A1 LHFPL2 MAPK10 MED12 | 1.90e-04 | 1275 | 106 | 14 | EFO_0004908 |
| Disease | anxiety, vitamin D measurement | 2.65e-04 | 7 | 106 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | serum gamma-glutamyl transferase measurement | TRPM7 CYP7A1 GPR39 SLC6A15 CSMD3 MPRIP THADA LHFPL2 FGFR2 IFT80 SNX9 | 4.53e-04 | 914 | 106 | 11 | EFO_0004532 |
| Disease | Liver Cirrhosis | 5.29e-04 | 103 | 106 | 4 | C0023890 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 5.65e-04 | 10 | 106 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | Fibrosis, Liver | 5.69e-04 | 105 | 106 | 4 | C0239946 | |
| Disease | prostate specific antigen measurement | 6.00e-04 | 188 | 106 | 5 | EFO_0004624 | |
| Disease | Other specified cardiac arrhythmias | 6.88e-04 | 11 | 106 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 6.88e-04 | 11 | 106 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 6.88e-04 | 11 | 106 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 6.88e-04 | 11 | 106 | 2 | C2748542 | |
| Disease | Oligospermia | 8.24e-04 | 12 | 106 | 2 | C0028960 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 9.72e-04 | 13 | 106 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Brugada Syndrome 1 | 9.72e-04 | 13 | 106 | 2 | C4551804 | |
| Disease | P wave duration | 1.30e-03 | 15 | 106 | 2 | EFO_0005094 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.30e-03 | 15 | 106 | 2 | C0428908 | |
| Disease | diverticular disease | 1.65e-03 | 236 | 106 | 5 | EFO_0009959 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 1.68e-03 | 17 | 106 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | unipolar depression, response to bupropion, mood disorder | 2.10e-03 | 19 | 106 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | Mental Depression | 2.27e-03 | 254 | 106 | 5 | C0011570 | |
| Disease | stem Cell Growth Factor beta measurement | 2.52e-03 | 75 | 106 | 3 | EFO_0008292 | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | apolipoprotein B measurement | 2.73e-03 | 663 | 106 | 8 | EFO_0004615 | |
| Disease | Endometrioma | 2.75e-03 | 161 | 106 | 4 | C0269102 | |
| Disease | Endometriosis | 2.75e-03 | 161 | 106 | 4 | C0014175 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.82e-03 | 22 | 106 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Brugada Syndrome (disorder) | 3.35e-03 | 24 | 106 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSLCSWVNVVVGRMT | 731 | Q8NHU2 | |
| ETITCILMDGKVMWS | 871 | Q7Z407 | |
| WMKLGNTGAMRRCVK | 916 | Q2NKJ3 | |
| MFINIKSILWMCSTL | 1 | P13611 | |
| MVMAALSLVAACWGR | 1 | Q8N9M1 | |
| NLTLKTLMGMRWVAT | 151 | Q9Y5Z6 | |
| TLMGMRWVATFCSKA | 156 | Q9Y5Z6 | |
| CWNMKMMIKTLATLV | 851 | Q96PN6 | |
| LCMQMGIIMVLKQTW | 646 | Q32M45 | |
| WCADKVAGMMVRELQ | 316 | Q9UPY3 | |
| KNLIQCWRECMAMSS | 971 | Q06278 | |
| SKRMCVLMITGSWII | 136 | Q8NG85 | |
| KKAMVWDMRSGQCVQ | 261 | O14775 | |
| NGIALMMWNTFLVKR | 1051 | Q9H2M9 | |
| MVSWGRFICLVVVTM | 1 | P21802 | |
| DMLHVVQKEWMRLCT | 376 | O75439 | |
| MQMARLLGLCAWARK | 1 | Q6PKH6 | |
| RMLMDIWTQKGNISL | 71 | Q8NH19 | |
| LMNRRVCLFMVVGSW | 136 | Q6IF00 | |
| MTSGIRRNWIQTIMK | 466 | Q6WCQ1 | |
| TLAVCWMPNQIRRIM | 291 | O43194 | |
| VPMVRATWLIKMTCA | 151 | Q86YW9 | |
| IWSVGCIMGEMVRHK | 246 | P53779 | |
| PVVCWMVCSGLKQQM | 396 | Q86W28 | |
| TLNVLWKMCGIDVHM | 3446 | Q2LD37 | |
| CNVTMVGKLWFVLTM | 16 | Q96KN9 | |
| WMTSRMKFLTCTQGP | 336 | A0A0J9YX94 | |
| CLKMIIMIWSISLAN | 141 | Q9Y3N9 | |
| CVALVVASWIMGVMH | 141 | Q8NGD2 | |
| IWMGNLLIMISITCT | 36 | Q8NGL7 | |
| AIQLMGIMCVLSVCW | 281 | P43115 | |
| RWHQRMSKMLQEICT | 251 | H3BV12 | |
| CGMILQEAMKWAPTV | 1061 | P42356 | |
| IWSVGCIMAEMLTGK | 206 | O15264 | |
| MCHVIVTCRSMLWTL | 1 | Q6ZUX7 | |
| VPVMRAAWLIKMTCA | 151 | Q93074 | |
| IMSCGMDHSLKLWRI | 251 | O75530 | |
| SLCMGWTIVRMKKSQ | 261 | Q86V85 | |
| MNRRVCLFMVVGSWV | 136 | Q8NGX2 | |
| CRMLLKRMVIVWSTG | 291 | Q9Y3T9 | |
| DVWLTMLSMIVGATC | 491 | Q9Y3Q4 | |
| MCAALVGMAWLVSHV | 141 | Q8NGR3 | |
| ALTLMGMFQWCVRQS | 986 | O15439 | |
| FRLVNTKCMVLVDMW | 526 | Q58A45 | |
| NLTIKTLMGMNWVAT | 226 | O43825 | |
| NGIEERMSMVWEKCV | 356 | O14531 | |
| DLWITMLSMIVGATC | 371 | O60741 | |
| VKEQTMWACLAAMAV | 611 | Q9P2H3 | |
| DTTRNLMICFLWIMK | 1291 | Q8NF50 | |
| QLMGAIKLCTGWMVT | 586 | Q7Z388 | |
| WSLGCMLASMIFRKE | 216 | P68400 | |
| AAVICMAWTLSVAMA | 141 | Q9NS66 | |
| LSLWVCEAQTVKKMM | 31 | Q17RS7 | |
| MMTTSLIWGIAIAAC | 1 | P22680 | |
| LPNNGSWSRVMCMLK | 401 | Q6UWR7 | |
| SMVKMVSTRCLPWRS | 426 | Q8IXS0 | |
| LAAKSLCMWVRAMEL | 3191 | Q9P225 | |
| QMRKCTLILMFAWFT | 346 | O75751 | |
| IHKTSQCMWLMQALG | 581 | O94829 | |
| MNMIWRNSISCLRLG | 1 | Q9H825 | |
| MVCLMALGFAWKRRA | 2186 | Q8TDX9 | |
| MHGKTSNLTRIWAMC | 141 | Q92523 | |
| SCHWAKGLRFMQMVR | 381 | Q6ZNG9 | |
| MNQTVCALLMAASWV | 136 | Q8NGN0 | |
| RMIWQEQSACIVMVT | 971 | Q15262 | |
| MTIISQWVCGVLMAV | 131 | Q8NGL9 | |
| LWGMIMTSSICLRQT | 266 | P03905 | |
| MNRRTCVQIAAGSWM | 136 | Q8NGS4 | |
| TMNRQVCGLLVAMAW | 156 | Q8NGB2 | |
| TAIGMMTRIAVLKWL | 411 | Q08AM6 | |
| SWMLLSCLMLLSQVQ | 11 | Q06141 | |
| AVMQISMCKKGIQVW | 426 | O95219 | |
| LQAWMTRMCRHPVIS | 331 | Q9Y5X1 | |
| WVMVCLAMIKGIQSS | 236 | Q9H2J7 | |
| VCMNVVQKLDHWLMS | 296 | Q6NUJ1 | |
| AQMVLVCCWRSMKEV | 1046 | Q6YHU6 | |
| MANIRCRPWTMGQKL | 61 | Q7Z5M5 | |
| RVLIHWMTLCQTQMK | 181 | Q8IUX1 | |
| LWEGKNMACVQRTLM | 116 | P37802 | |
| MSMVKSFVQWLGCRS | 651 | O60502 | |
| RTTLKLQGQMIWMES | 271 | O75343 | |
| AMQMTCKLGGELWAV | 596 | Q7Z3Z4 | |
| TLLLCNMVINVMFWK | 911 | Q7Z443 | |
| KGVLVRCMLNIWGVM | 181 | Q13621 | |
| VLKWLFRMMSVHTDC | 806 | Q8IX21 | |
| MRMQAALVGWACTTL | 1 | A0A1B0GV85 | |
| LTKMCTIRMSFVKGW | 406 | Q99717 | |
| LTKMCTIRMSFVKGW | 406 | Q15797 | |
| AWKVTDECIQIMGGM | 426 | P49748 | |
| GKCMAKMILSVWLLS | 196 | P34969 | |
| KSMIGMSTKAVLWRC | 316 | Q96KA5 | |
| VACTNWKRLMMVLTG | 126 | Q9NPF2 | |
| SWLQVPMMVRGLCTA | 236 | Q6ZU45 | |
| GFLMWRNSKVMNIVS | 181 | Q9Y548 | |
| SWNRAEMTMCALLAK | 51 | Q86TZ1 | |
| LMSRAVASMVWKECF | 636 | Q99797 | |
| IENMWACMEVGQKSI | 851 | Q9Y5Y9 | |
| LTRMCTIRMSFVKGW | 366 | P84022 | |
| MGPWSRVRVAKCQML | 1 | Q96QS1 | |
| RIWRMNKAGQVMCVA | 401 | Q12788 | |
| RVWSMDNMICTQTLL | 626 | Q6Q0C0 | |
| FGWVKGVMIRCMLNI | 136 | P55017 | |
| SLVSCGLDMQVMLWS | 151 | Q7Z5U6 | |
| GLDMQVMLWSLQKAR | 156 | Q7Z5U6 | |
| LKIAWLMQVTMGTTA | 291 | O00337 | |
| GRMFVLIWAMCISVK | 486 | Q8NET8 | |
| KMTLCLLVAWSIVGM | 226 | Q9H1V8 | |
| RSGSQCLSKWKIMMG | 486 | Q5SXM2 | |
| CQQLWRMGMLGTRVL | 181 | Q6UX68 | |
| RQAWEVIKCFLVAMM | 961 | Q9Y4A5 | |
| MRETIRNLNCIGMKW | 81 | P15621 | |
| MVTCGTDRIVKIWDM | 381 | Q8IWB7 | |
| LIWACLMKRQVMARF | 626 | Q96QT4 | |
| MASKIGSRRWMLQLI | 1 | Q96IK0 | |
| LDTLMWGMLNRKAQV | 451 | Q5FWF4 | |
| NKMGRWLCSLIGMLV | 361 | P54219 | |
| LRKDMCSWSKGMQIR | 1706 | Q9Y4I1 | |
| LRQSCVMVQKHMRGW | 756 | Q9NQX4 |